Skip to main content
. 2021 Jul 14;12:703481. doi: 10.3389/fpsyt.2021.703481

Figure 2.

Figure 2

Cognitive and neuropsychiatric changes between the AD groups. The changes in the cognitive and neuropsychiatric scores before and after the COVID-19 pandemic are described in A–E. The point percentages of the 12 NPI items are described to show the comparison before (control group) and after COVID-19 (COVID-19 exposure group) at baseline and at the 1-year follow up. AD, Alzheimer's disease; C-MMSE, Chinese Mini-Mental State Examination; MoCA, the Montreal Cognitive Assessment; ADL, activities of daily living; NPI, the Neuropsychiatric Inventory. *p < 0.05.